ACT Advisors »

Actuate Therapeutics shares owned by ACT Advisors

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by ACT Advisors from 13F filings

Historical chart of ACT Advisors investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by ACT Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by ACT Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $20k 13k 1.53

More positions owned by ACT Advisors

Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Intl Eqt Etf (AVDE)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Capital Group Dividend Value Shs Creat Unit (CGDV)
Ishares Tr Core S&p500 Etf (IVV)
New York Life Invts Active E Mack Mu Insd Etf (MMIN)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust St Str P500etf (SPYM)
2023 Etf Series Trust Eagl Cap Sel Etf (EAGL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)

View all positions for ACT Advisors

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Capital Management
AQR Capital Management
Geode Capital Management
Texas Capital Bank Wealth Management Services
Palogic Value Management
Millennium Management
BlackRock
ABS Direct Equity Fund
ABS Investment Management
State Street Corporation
Vanguard Fiduciary Trust
Rock Creek Group
Jane Street

View all funds holding Actuate Therapeutics